Number of the records: 1
skúšanie klinické, fáza I, ako téma
SYS d017321 LBL 00000cx--j2200000---45-- 005 20240119201421.6 100 $a 19920513asloy0103----ba0 152 $b mesh 250 $a skúšanie klinické, fáza I, ako téma $x CL $x EC $x ES $x HI $x IS $x LJ $x MT $x PX $x SN $x ST $x VE $8 slo 300 1-
$a 2008(1993) $8 eng 300 1-
$a Clinical Trials (1980-1992) $8 eng 300 1-
$a Drug Evaluation (1980-1992) $8 eng 330 1-
$a Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries. $8 eng 450 $a Clinical Trials, Phase I $5 e $8 eng 450 $a Drug Evaluation, FDA Phase I $5 e $8 eng 450 $a Evaluation Studies, FDA Phase I $5 e $8 eng 450 $a Human Microdosing Trial $5 e $8 eng 450 $a Phase 1 Clinical Trial $5 e $8 eng 450 $a Phase I Clinical Trial $5 e $8 eng 450 $a Phase I Clinical Trials $5 e $8 eng 450 $a štúdie klinické, fáza I $5 e $8 slo 450 $a štúdie klinické, fáza I, ako téma $5 e $8 slo 450 $a pokusy klinické, prvá fáza, ako téma $5 e $8 slo 450 $a testy klinické, prvá fáza, ako téma $5 e $8 slo 450 $a štúdie vyhodnocovacie, FDA fáza I, ako téma $5 e $8 slo 450 $a štúdie vyhodnocovacie, FDA fáza I $5 e $8 slo 450 $a štúdie hodnotiace, FDA fáza 1, ako téma $5 e $8 slo 450 $a hodnotenie liekov, FDA fáza I, ako téma $5 e $8 slo 450 $a štúdia mikrodávková humánna $5 e $8 slo 450 $a skúška klinická, fáza 1 $5 e $8 slo 550 $3 sllk_un_auth*d033281 $Y Nontherapeutic Human Experimentation $5 F $a experimentovanie na ľuďoch, neterapeutické 550 $3 sllk_un_auth*d033281 $Y Nontherapeutic Human Experimentation $5 B $a experimentovanie na ľuďoch, neterapeutické 675 $a 615.036 686 $a E05.318.372.250.250.200 686 $a N05.715.360.330.250.250.200 686 $a N06.850.520.450.250.250.200 750 $a Clinical Trials, Phase I as Topic $8 eng 801 -0
$a US $b DNLM $c 19920513 801 -2
$a SK $b BA006 $c 19990922 801 -2
$a SK $b BA006 $c 20080702 801 -2
$a SK $b BA006 $c 20160216 801 -2
$a SK $b BA006 $c 20160509 801 -2
$a SK $b BA006 $c 20220108 820 $a for general design, methodology, economics, etc. of phase I clinical trials; a different heading CLINICAL TRIAL, PHASE I is used for reports of a specific phase I clinical trial $8 eng 980 $x M
Number of the records: 1